← 返回

NK 细胞上的抑制性受体与检查点:对癌症免疫治疗的意义

英文原题:Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy.

查看英文原题

Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy.

PubMed 2023/11/29(内容时间) Pathol Res Pract Q1 · IF 3.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

随着免疫抑制性检查点在肿瘤治疗中的成功应用,相应的不良反应和耐药缺陷逐渐显现。T细胞和NK细胞是人体免疫系统的两支重要力量。近年来,T细胞检查点研究一度遇到瓶颈,例如PD-1的作用并不理想;而正常情况下,NK细胞表面激活性与抑制性受体的分布维持稳态,靶向阻断这些受体可能对肿瘤治疗有益。本文综述NK细胞功能及相应受体在多种肿瘤中的作用,为未来选择合适的检查点靶位提供方向。

展开英文摘要原文

With the success of immunosuppressive checkpoint in tumor therapy, the corresponding adverse response and drug resistance defects have been exposed. T cells and NK cells are the body's immune system of the two substantial main forces.

in recent years, study of T cell checkpoints appeared a certain block, such as PD-1 the effect not benign, on the distribution of NK cell surface excitatory and inhibitory receptors under normal conditions to maintain steady, could be targeted in the tumor treatment blockade have therapeutic effect. This paper reviews the function of NK cells and the effects of corresponding receptors in various types of tumors, providing a direction for the selection of appropriate gate control sites for future treatment.

论文信息

作者
Li L、Li A、Jin H、Li M、Jia Q
第一作者单位
State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.China
通讯作者单位
Department of Reproductive Medicine, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China. Electronic address: 361400283@qq.com.China
文献类型
综述
期刊
Pathology, research and practice2024 Jan
原文标识
PubMed 38042093 · DOI 10.1016/j.prp.2023.155003